Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2026)

Organogenesis Holdings' Non Operating Income history runs 10 years deep, the most recent figure standing at $418000.0 for Q1 2026.

• On a quarterly basis, Non Operating Income fell 56.59% year-over-year to $418000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 2572.86% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 249.34% from the prior year.
• Non Operating Income climbed to $418000.0 in Q1 2026 per ORGO's latest filing, from $138000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $963000.0 in Q1 2025 and bottomed at -$751000.0 in Q2 2022.
• The 5-year median for Non Operating Income is -$419000.0 (2024), against an average of -$175529.4.
• Across the five-year window, Non Operating Income plunged 1563.89% in 2023 and soared 305.88% in 2025, its largest moves.
• Year by year, Non Operating Income stood at $36000.0 in 2022, then plunged by 1563.89% to -$527000.0 in 2023, then jumped by 106.45% to $34000.0 in 2024, then surged by 305.88% to $138000.0 in 2025, then jumped by 202.9% to $418000.0 in 2026.
• Per Business Quant, the three latest ORGO Non Operating Income figures stand at $418000.0 (Q1 2026), $138000.0 (Q4 2025), and $433000.0 (Q3 2025).